Asthma is known as chronic disease as there is no permanent treatment for it. Asthma is a disorder in which the airways constrict and swell, causing more mucus to be produced. This can make breathing difficult, resulting in coughing, a whistling sound (wheezing) on exhalation, and shortness of breath. Environmental variables such as pollen, animal dander, dust, or smoking are frequently responsible for the onset of asthma. Asthma spacers are empty tubes, generally composed of plastic. On one end, spacer fit into the mouthpiece of inhaler, and on the other end, they fit to a mouthpiece or mask. It assists the patient in getting the most out of the asthma medication with metered dosage inhaler (MDI). There are numerous brands of asthma spacers available on prescription that suit various inhalers including volumatic, aerochamber, able spacer, space chamber plus, and a2a spacer. Spacers are being used to promote medication consumption. MDI with spacers is a good substitute for nebulizers. Furthermore, nebulizer therapy is more expensive than ‘metered-dose inhaler with spacer' therapy and necessitates more equipment and maintenance to avoid contamination.
Market Dynamics
Increasing technological advancement in asthma spacer is estimated to push the global asthma spacer market growth over the forecast period. For instance, in February 2018, Trudell Medical International claims its new AeroChamber Plus Flow-Vu Anti-Static Valved Holding Chamber (VHC) spacer. This is the company’s most advanced spacer or chamber. The spacer is predominately aimed at patients who struggle with the coordination of administering with metered-dose inhaler (MDI) medicines.
Key features of the study:
- This report provides an in-depth analysis of the global asthma spacer market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global asthma spacer market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Trudell Medical International, PARI Respiratory Equipment, Inc., Koninklijke Philips N.V, Lupin, GlaxoSmithKline Plc., Medical Developments International, Visiomed Group Ltd., Cipla Inc., Clement Clarke international Ltd., Rossmax International Ltd., Luckys Pharma, Mediacare Equipments (India) Pvt. Ltd., Asia Connection Co., Ltd., and Laboratoire Protecsom SAS.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global asthma spacer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have an ease in decision-making through various strategy matrices used in analysing the global asthma spacer market
Detailed Segmentation:
- Global Asthma Spacer Market, By Spacer Type:
- Volumatic
- Aerochamber
- InspirEase
- Optichamber
- Others
- Global Asthma Spacer Market, By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Global Asthma Spacer Market, By Region:
- North America
- By Spacer Type
- Volumatic
- Aerochamber
- InspirEase
- Optichamber
- Others
- By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- By Country
- Latin America
- By Spacer Type
- Volumatic
- Aerochamber
- InspirEase
- Optichamber
- Others
- By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Spacer Type
- Volumatic
- Aerochamber
- InspirEase
- Optichamber
- Others
- By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Spacer Type
- Volumatic
- Aerochamber
- InspirEase
- Optichamber
- Others
- By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Spacer Type
- Volumatic
- Aerochamber
- InspirEase
- Optichamber
- Others
- By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Spacer Type
- Volumatic
- Aerochamber
- InspirEase
- Optichamber
- Others
- By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- By Country/Region
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Trudell Medical International *
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- PARI Respiratory Equipment, Inc.
- Koninklijke Philips N.V
- GlaxoSmithKline Plc.
- Lupin
- Medical Developments International
- Visiomed Group Ltd.
- Cipla Inc.
- Clement Clarke International Ltd.
- Rossmax International Ltd.
- Luckys Pharma
- Mediacare Equipments (India) Pvt. Ltd.
- Asia Connection Co., Ltd.
- Laboratoire Protecsom SAS
“*” marked represents similar segmentation in other categories in the respective section.
